Mylan Signs Deal With Indian Firm To Develop 22 Oral Contraceptives

Main Category: Sexual Health / STDs
Also Included In: Pharma Industry / Biotech Industry
Article Date: 11 Aug 2008 - 8:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Mylan on Wednesday announced a deal with Indian drug maker Famy Care to develop and sell 22 generic oral contraceptive products, the Pittsburgh Tribune-Review reports (Stouffer, Pittsburgh Tribune-Review, 8/7). Mylan plans to seek FDA approval for the products over the next few months and hopes to begin marketing them in 2010. Under the terms of the deal, Mylan can sell other contraceptives in other markets, including Australia and Japan. Mylan did not disclose financial terms of the deal (AP/Yahoo! News, 8/6).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2008 The Advisory Board Company. All rights reserved.